Theraclion S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TCLIF research report →
Price Chart
About the company
Theraclion SA specializes in developing advanced echotherapy devices that harness high-intensity focused ultrasound technology. Its product portfolio includes SONOVEIN, a robotic, non-surgical echotherapy system specifically designed for treating varicose veins. Another key offering is ECHOPULSE, also a robotic and non-invasive echotherapy solution, utilized for addressing thyroid nodules and breast fibroadenomas.
- CEO
- Martin Deterre
- IPO
- 2019
- Employees
- 36
- HQ
- Malakoff, IF, FR
Get TickerSpark's AI analysis on TCLIF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $38.89M
- P/E
- -6.04
- PEG
- -1.05
- P/S
- 40.56
- P/B
- -14.79
- EV/EBITDA
- -8.40
- Div Yield
- 0.00%
- Gross Margin
- -528.16%
- Op Margin
- -424.37%
- Net Margin
- -479.76%
- ROE
- 222.05%
- ROIC
- -49.80%
Latest fiscal year · YoY change
- Revenue
- $1.19M+42.8%
- Gross Profit
- $-6,915,408+3.7%
- Op Income
- $-6,378,609.8
- Net Income
- $-5,687,868+1.2%
- EPS
- $-0.09+28.0%
- OCF Growth
- -145.9%
- FCF Growth
- -137.6%
- 52W High
- $0.59
- 52W Low
- $0.00
- 50D MA
- $0.53
- 200D MA
- $0.25
- Beta
- 0.39
- RSI (14)
- 100
- Avg Volume
- 80
No earnings-call transcripts are available for TCLIF yet.
- Free Float
- 71.0%
- Shares Outstanding
- 73.10M
- Float Shares
- 51.92M
Our TCLIF coverage
Recent articles, reports, and earnings notes.
No research on TCLIF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TCLIF report →